The Antipsychotic Dopamine 2 Receptor Antagonist Diphenylbutylpiperidines Improve Glycemia in Experimental Obesity by Inhibiting Succinyl-CoA:3-Ketoacid CoA Transferase

Seyed Amirhossein Tabatabaei Dakhili(University of Alberta), John R. Ussher(University of Alberta), Peter A. Crawford(University of Minnesota System), Rabih Abou Farraj(University of Alberta), Crystal Lee(Deakin University), Kunyan Yang(University of Alberta), Farah Eaton(University of Alberta), J. N. Mark Glover(University of Alberta), Jadin J. Chahade(University of Alberta), Amanda A. Greenwell(University of Alberta), Jordan S. F. Chan(University of Alberta), Keshav Gopal(University of Alberta), Rami Al Batran(Université de Montréal), Carlos A. Velázquez-Martínez(University of Alberta), Christina T. Saed(University of Alberta)
Diabetes
October 18, 2022
Cited by 14


Related Papers